4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-24-000043
Chief Executive Officer returned 9,727 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Virnich Daniel · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-20 | Returned to the company : show line 1 in the form | −4,750 | $0.14 | $646 | 716,961 | D |
| 2024-11-20 | Returned to the company : show line 2 in the form | −4,977 | $0.14 | $677 | 711,984 | D |
Loading xslF345X05/wk-form4_1732231374.xml…